Last reviewed · How we verify

NCT05736705

Monopolar and Bipolar in Esophageal ESD

Withdrawn NA Last updated 27 June 2024
What this trial tests

NA trial testing Endoscopic Submucosal Dissection in Esophageal Neoplasm. Withdrawn.

Timeline
23 January 2023
Primary endpoint
25 June 2024
25 June 2024

Quick facts

Lead sponsorBaylor College of Medicine
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Start date23 January 2023
Primary completion25 June 2024
Estimated completion25 June 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Baylor College of Medicine

Who can join

Adults 18 to 90, any sex, with Esophageal Neoplasm or Esophageal Polyp. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to prospectively document the efficacy and clinical outcomes of Endoscopic Submucosal Dissection procedure that utilize either a novel Bipolar-Current ESD device or the standard monopolar electrocautery knife.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Endoscopic Submucosal Dissection

Trials testing the same drug.

Other recruiting trials for Esophageal Neoplasm

Currently open trials in the same condition.

Other Baylor College of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05736705.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing